#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


1-1	0-8	Aberrant	_
1-2	9-37	blood-oxygen-level-dependent	_
1-3	38-44	signal	_
1-4	45-57	oscillations	_
1-5	58-64	across	_
1-6	65-74	frequency	_
1-7	75-80	bands	_
1-8	81-93	characterize	_
1-9	94-97	the	_
1-10	98-107	alcoholic	_
1-11	108-113	brain	_
1-12	114-121	Chronic	_
1-13	122-132	alcoholism	_
1-14	133-135	is	_
1-15	136-146	associated	_
1-16	147-151	with	_
1-17	152-162	widespread	_
1-18	163-171	regional	_
1-19	172-183	differences	_
1-20	184-188	from	_
1-21	189-197	controls	_
1-22	198-200	in	_
1-23	201-206	brain	_
1-24	207-215	activity	_
1-25	216-219	and	_
1-26	220-232	connectivity	_
1-27	233-241	dynamics	_
1-28	242-250	measured	_
1-29	251-253	by	_
1-30	254-282	blood-oxygen-level-dependent	_
1-31	283-284	(	_
1-32	285-289	BOLD	_
1-33	290-291	)	_
1-34	292-299	signals	_
1-35	300-301	.	_

2-1	302-316	Identification	_
2-2	317-319	of	_
2-3	320-338	alcoholism-related	_
2-4	339-354	neurofunctional	_
2-5	355-360	power	_
2-6	361-369	dynamics	_
2-7	370-375	using	_
2-8	376-386	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-9	387-395	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-10	396-405	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-11	406-413	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-12	414-415	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-13	416-420	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-14	421-422	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
2-15	423-427	that	_
2-16	428-434	relate	_
2-17	435-437	to	_
2-18	438-447	cognition	_
2-19	448-451	and	_
2-20	452-460	behavior	_
2-21	461-464	may	_
2-22	465-470	serve	_
2-23	471-473	as	_
2-24	474-484	biomarkers	_
2-25	485-487	of	_
2-26	488-498	alcoholism	_
2-27	499-500	.	_

3-1	501-511	Previously	_
3-2	512-513	,	_
3-3	514-527	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
3-4	528-532	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
3-5	533-540	studies	_
3-6	541-549	examined	_
3-7	550-554	BOLD	_
3-8	555-562	signals	_
3-9	563-565	at	_
3-10	566-567	a	_
3-11	568-574	single	_
3-12	575-588	low-frequency	_
3-13	589-590	(	_
3-14	591-593	LF	_
3-15	594-595	)	_
3-16	596-605	bandwidth	_
3-17	606-607	.	_

4-1	608-612	BOLD	_
4-2	613-620	signals	_
4-3	621-622	,	_
4-4	623-630	however	_
4-5	631-632	,	_
4-6	633-642	oscillate	_
4-7	643-657	systematically	_
4-8	658-660	at	_
4-9	661-670	different	_
4-10	671-682	frequencies	_
4-11	683-686	and	_
4-12	687-690	are	_
4-13	691-700	organized	_
4-14	701-703	in	_
4-15	704-705	a	_
4-16	706-713	resting	_
4-17	714-719	brain	_
4-18	720-725	where	_
4-19	726-728	LF	_
4-20	729-740	oscillation	_
4-21	741-752	facilitates	_
4-22	753-766	long-distance	_
4-23	767-780	communication	_
4-24	781-788	between	_
4-25	789-796	regions	_
4-26	797-803	across	_
4-27	804-812	cortical	_
4-28	813-820	regions	_
4-29	821-822	,	_
4-30	823-830	whereas	_
4-31	831-845	high-frequency	_
4-32	846-847	(	_
4-33	848-850	HF	_
4-34	851-852	)	_
4-35	853-864	oscillation	_
4-36	865-871	occurs	_
4-37	872-874	in	_
4-38	875-882	closely	_
4-39	883-892	localized	_
4-40	893-894	,	_
4-41	895-906	subcortical	_
4-42	907-912	areas	_
4-43	913-914	.	_

5-1	915-920	Using	_
5-2	921-922	a	_
5-3	923-932	frequency	_
5-4	933-938	power	_
5-5	939-953	quantification	_
5-6	954-962	approach	_
5-7	963-964	,	_
5-8	965-967	we	_
5-9	968-980	investigated	_
5-10	981-988	whether	_
5-11	989-992	the	_
5-12	993-1005	organization	_
5-13	1006-1008	of	_
5-14	1009-1013	BOLD	_
5-15	1014-1020	signal	_
5-16	1021-1033	oscillations	_
5-17	1034-1040	across	_
5-18	1041-1044	all	_
5-19	1045-1053	measured	_
5-20	1054-1063	frequency	_
5-21	1064-1074	bandwidths	_
5-22	1075-1077	is	_
5-23	1078-1085	altered	_
5-24	1086-1088	in	_
5-25	1089-1099	alcoholism	_
5-26	1100-1103	and	_
5-27	1104-1111	relates	_
5-28	1112-1114	to	_
5-29	1115-1124	cognitive	_
5-30	1125-1136	performance	_
5-31	1137-1138	.	_

6-1	1139-1158	Frequency-dependent	_
6-2	1159-1170	oscillation	_
6-3	1171-1176	power	_
6-4	1177-1188	differences	_
6-5	1189-1196	between	_
6-6	1197-1199	56	_
6-7	1200-1205	sober	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
6-8	1206-1216	alcoholics	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
6-9	1217-1220	and	_
6-10	1221-1223	56	_
6-11	1224-1231	healthy	_
6-12	1232-1240	controls	_
6-13	1241-1249	occurred	_
6-14	1250-1253	for	_
6-15	1254-1257	all	_
6-16	1258-1267	frequency	_
6-17	1268-1273	bands	_
6-18	1274-1275	.	_

7-1	1276-1286	Alcoholics	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
7-2	1287-1296	exhibited	_
7-3	1297-1304	greater	_
7-4	1305-1314	frequency	_
7-5	1315-1326	oscillation	_
7-6	1327-1332	power	_
7-7	1333-1335	in	_
7-8	1336-1339	the	_
7-9	1340-1353	orbitofrontal	_
7-10	1354-1360	cortex	_
7-11	1361-1364	and	_
7-12	1365-1369	less	_
7-13	1370-1375	power	_
7-14	1376-1378	in	_
7-15	1379-1382	the	_
7-16	1383-1392	posterior	_
7-17	1393-1399	insula	_
7-18	1400-1406	within	_
7-19	1407-1410	the	_
7-20	1411-1413	HF	_
7-21	1414-1423	bandwidth	_
7-22	1424-1428	than	_
7-23	1429-1437	controls	_
7-24	1438-1439	.	_

8-1	1440-1448	Aberrant	_
8-2	1449-1462	orbitofrontal	_
8-3	1463-1465	HF	_
8-4	1466-1471	power	_
8-5	1472-1475	was	_
8-6	1476-1486	associated	_
8-7	1487-1491	with	_
8-8	1492-1498	poorer	_
8-9	1499-1505	memory	_
8-10	1506-1517	performance	_
8-11	1518-1521	and	_
8-12	1522-1528	slower	_
8-13	1529-1540	psychomotor	_
8-14	1541-1546	speed	_
8-15	1547-1549	in	_
8-16	1550-1560	alcoholics	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
8-17	1561-1562	.	_

9-1	1563-1579	Middle-frequency	_
9-2	1580-1583	and	_
9-3	1584-1586	LF	_
9-4	1587-1592	power	_
9-5	1593-1599	proved	_
9-6	1600-1609	sensitive	_
9-7	1610-1612	in	_
9-8	1613-1622	detecting	_
9-9	1623-1630	altered	_
9-10	1631-1640	frequency	_
9-11	1641-1652	oscillation	_
9-12	1653-1661	dynamics	_
9-13	1662-1664	in	_
9-14	1665-1673	parietal	_
9-15	1674-1677	and	_
9-16	1678-1689	postcentral	_
9-17	1690-1698	cortical	_
9-18	1699-1706	regions	_
9-19	1707-1709	of	_
9-20	1710-1720	alcoholics	_
9-21	1721-1722	.	_

10-1	1723-1727	This	_
10-2	1728-1733	study	_
10-3	1734-1736	is	_
10-4	1737-1742	novel	_
10-5	1743-1745	in	_
10-6	1746-1757	identifying	_
10-7	1758-1773	alcohol-related	_
10-8	1774-1785	differences	_
10-9	1786-1788	in	_
10-10	1789-1793	BOLD	_
10-11	1794-1805	oscillation	_
10-12	1806-1811	power	_
10-13	1812-1814	of	_
10-14	1815-1818	the	_
10-15	1819-1823	full	_
10-16	1824-1828	fMRI	_
10-17	1829-1838	frequency	_
10-18	1839-1848	bandwidth	_
10-19	1849-1850	.	_

11-1	1851-1863	Specifically	_
11-2	1864-1865	,	_
11-3	1866-1868	HF	_
11-4	1869-1874	power	_
11-5	1875-1886	aberrations	_
11-6	1887-1891	were	_
11-7	1892-1902	associated	_
11-8	1903-1907	with	_
11-9	1908-1914	poorer	_
11-10	1915-1924	cognitive	_
11-11	1925-1936	functioning	_
11-12	1937-1939	in	_
11-13	1940-1950	alcoholism	http://maven.renci.org/NeuroBridge/neurobridge#StructuredAssessmentfortheGeneticsofAlcoholism
11-14	1951-1954	and	_
11-15	1955-1958	may	_
11-16	1959-1964	serve	_
11-17	1965-1967	as	_
11-18	1968-1969	a	_
11-19	1970-1979	biomarker	_
11-20	1980-1983	for	_
11-21	1984-1995	identifying	_
11-22	1996-2002	neural	_
11-23	2003-2010	targets	_
11-24	2011-2014	for	_
11-25	2015-2021	repair	_
11-26	2022-2023	.	_

12-1	2024-2033	MATERIALS	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
12-2	2034-2037	AND	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
12-3	2038-2045	METHODS	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
12-4	2046-2054	Subjects	_
12-5	2055-2058	The	_
12-6	2059-2066	dataset	_
12-7	2067-2076	comprised	_
12-8	2077-2079	56	_
12-9	2080-2089	alcoholic	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
12-10	2090-2098	subjects	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
12-11	2099-2100	(	_
12-12	2101-2103	17	_
12-13	2104-2109	women	_
12-14	2110-2111	)	_
12-15	2112-2115	and	_
12-16	2116-2118	56	_
12-17	2119-2130	age-matched	_
12-18	2131-2138	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
12-19	2139-2147	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
12-20	2148-2149	(	_
12-21	2150-2152	17	_
12-22	2153-2158	women	_
12-23	2159-2160	)	_
12-24	2161-2162	(	_
12-25	2163-2168	Table	_
12-26	2169-2170	1	_
12-27	2171-2172	)	_
12-28	2173-2174	.	_

13-1	2175-2178	The	_
13-2	2179-2181	56	_
13-3	2182-2192	alcoholics	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
13-4	2193-2197	were	_
13-5	2198-2207	recruited	_
13-6	2208-2212	from	_
13-7	2213-2218	local	_
13-8	2219-2233	rehabilitation	_
13-9	2234-2236	or	_
13-10	2237-2246	addiction	_
13-11	2247-2256	treatment	_
13-12	2257-2264	centers	_
13-13	2265-2272	through	_
13-14	2273-2287	advertisements	_
13-15	2288-2289	,	_
13-16	2290-2298	referral	_
13-17	2299-2301	or	_
13-18	2302-2306	word	_
13-19	2307-2309	of	_
13-20	2310-2315	mouth	_
13-21	2316-2317	.	_

14-1	2318-2321	The	_
14-2	2322-2330	controls	_
14-3	2331-2335	were	_
14-4	2336-2346	volunteers	_
14-5	2347-2351	from	_
14-6	2352-2355	the	_
14-7	2356-2361	local	_
14-8	2362-2373	communities	_
14-9	2374-2375	.	_

15-1	2376-2379	All	_
15-2	2380-2383	the	_
15-3	2384-2392	subjects	_
15-4	2393-2401	provided	_
15-5	2402-2409	written	_
15-6	2410-2418	informed	_
15-7	2419-2426	consent	_
15-8	2427-2429	to	_
15-9	2430-2441	participate	_
15-10	2442-2444	in	_
15-11	2445-2449	this	_
15-12	2450-2455	study	_
15-13	2456-2457	.	_

16-1	2458-2461	The	_
16-2	2462-2473	recruitment	_
16-3	2474-2477	and	_
16-4	2478-2483	study	_
16-5	2484-2494	procedures	_
16-6	2495-2499	were	_
16-7	2500-2508	approved	_
16-8	2509-2511	by	_
16-9	2512-2515	the	_
16-10	2516-2529	Institutional	_
16-11	2530-2536	Review	_
16-12	2537-2543	Boards	_
16-13	2544-2546	of	_
16-14	2547-2555	Stanford	_
16-15	2556-2566	University	_
16-16	2567-2573	School	_
16-17	2574-2576	of	_
16-18	2577-2585	Medicine	_
16-19	2586-2589	and	_
16-20	2590-2593	SRI	_
16-21	2594-2607	International	_
16-22	2608-2609	.	_

17-1	2610-2619	Screening	_
17-2	2620-2623	was	_
17-3	2624-2633	conducted	_
17-4	2634-2636	by	_
17-5	2637-2645	clinical	_
17-6	2646-2654	research	_
17-7	2655-2668	psychologists	_
17-8	2669-2671	or	_
17-9	2672-2680	research	_
17-10	2681-2687	nurses	_
17-11	2688-2690	on	_
17-12	2691-2694	the	_
17-13	2695-2700	basis	_
17-14	2701-2703	of	_
17-15	2704-2707	the	_
17-16	2708-2718	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-17	2719-2727	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-18	2728-2737	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-19	2738-2741	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-20	2742-2748	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
17-21	2749-2750	.	_

18-1	2751-2754	For	_
18-2	2755-2758	all	_
18-3	2759-2767	subjects	_
18-4	2768-2769	,	_
18-5	2770-2773	the	_
18-6	2774-2783	exclusion	_
18-7	2784-2791	factors	_
18-8	2792-2796	were	_
18-9	2797-2802	DSMIV	_
18-10	2803-2811	criteria	_
18-11	2812-2815	for	_
18-12	2816-2821	other	_
18-13	2822-2826	Axis	_
18-14	2827-2828	I	_
18-15	2829-2838	diagnoses	_
18-16	2839-2840	.	_

19-1	2841-2843	In	_
19-2	2844-2847	the	_
19-3	2848-2857	alcoholic	_
19-4	2858-2863	group	_
19-5	2864-2865	,	_
19-6	2866-2868	55	_
19-7	2869-2877	subjects	_
19-8	2878-2881	met	_
19-9	2882-2888	DSM-IV	_
19-10	2889-2897	criteria	_
19-11	2898-2901	for	_
19-12	2902-2909	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
19-13	2910-2920	dependence	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
19-14	2921-2922	,	_
19-15	2923-2926	and	_
19-16	2927-2930	one	_
19-17	2931-2938	subject	_
19-18	2939-2942	met	_
19-19	2943-2951	criteria	_
19-20	2952-2955	for	_
19-21	2956-2963	alcohol	_
19-22	2964-2969	abuse	http://maven.renci.org/NeuroBridge/neurobridge#BarbiturateAbuse
19-23	2970-2971	.	_

20-1	2972-2974	Of	_
20-2	2975-2980	those	_
20-3	2981-2988	meeting	_
20-4	2989-2999	dependence	_
20-5	3000-3008	criteria	_
20-6	3009-3010	,	_
20-7	3011-3013	35	_
20-8	3014-3018	were	_
20-9	3019-3021	in	_
20-10	3022-3027	early	_
20-11	3028-3032	full	_
20-12	3033-3042	remission	_
20-13	3043-3044	(	_
20-14	3045-3048	met	_
20-15	3049-3051	no	_
20-16	3052-3059	alcohol	_
20-17	3060-3070	dependence	_
20-18	3071-3079	criteria	_
20-19	3080-3083	for	_
20-20	3084-3085	<	_
20-21	3086-3087	1	_
20-22	3088-3092	year	_
20-23	3093-3094	)	_
20-24	3095-3096	,	_
20-25	3097-3099	12	_
20-26	3100-3104	were	_
20-27	3105-3107	in	_
20-28	3108-3117	sustained	_
20-29	3118-3122	full	_
20-30	3123-3132	remission	_
20-31	3133-3134	(	_
20-32	3135-3138	met	_
20-33	3139-3141	no	_
20-34	3142-3149	alcohol	_
20-35	3150-3160	dependence	_
20-36	3161-3169	criteria	_
20-37	3170-3173	for	_
20-38	3174-3175	>	_
20-39	3176-3177	1	_
20-40	3178-3182	year	_
20-41	3183-3184	)	_
20-42	3185-3186	,	_
20-43	3187-3188	5	_
20-44	3189-3193	were	_
20-45	3194-3196	in	_
20-46	3197-3202	early	_
20-47	3203-3210	partial	_
20-48	3211-3220	remission	_
20-49	3221-3222	(	_
20-50	3223-3226	met	_
20-51	3227-3228	<	_
20-52	3229-3230	3	_
20-53	3231-3238	alcohol	_
20-54	3239-3249	dependence	_
20-55	3250-3258	criteria	_
20-56	3259-3265	within	_
20-57	3266-3269	the	_
20-58	3270-3274	past	_
20-59	3275-3277	12	_
20-60	3278-3284	months	_
20-61	3285-3286	)	_
20-62	3287-3290	and	_
20-63	3291-3292	4	_
20-64	3293-3296	did	_
20-65	3297-3300	not	_
20-66	3301-3305	meet	_
20-67	3306-3315	remission	_
20-68	3316-3324	criteria	_
20-69	3325-3326	.	_

21-1	3327-3330	The	_
21-2	3331-3337	median	_
21-3	3338-3344	number	_
21-4	3345-3347	of	_
21-5	3348-3353	weeks	_
21-6	3354-3359	since	_
21-7	3360-3370	alcoholics	_
21-8	3371-3375	last	_
21-9	3376-3379	met	_
21-10	3380-3390	dependence	_
21-11	3391-3399	criteria	_
21-12	3400-3403	was	_
21-13	3404-3408	21.6	_
21-14	3409-3414	weeks	_
21-15	3415-3416	[	_
21-16	3417-3421	mean	_
21-17	3422-3423	=	_
21-18	3424-3428	78.5	_
21-19	3429-3434	weeks	_
21-20	3435-3436	,	_
21-21	3437-3445	standard	_
21-22	3446-3455	deviation	_
21-23	3456-3457	=	_
21-24	3458-3463	146.9	_
21-25	3464-3469	weeks	_
21-26	3470-3471	]	_
21-27	3472-3473	.	_

22-1	3474-3477	The	_
22-2	3478-3484	median	_
22-3	3485-3488	age	_
22-4	3489-3491	of	_
22-5	3492-3502	alcoholism	http://maven.renci.org/NeuroBridge/neurobridge#DelayedOnsetPostTraumaticStressDisorder
22-6	3503-3508	onset	http://maven.renci.org/NeuroBridge/neurobridge#DelayedOnsetPostTraumaticStressDisorder
22-7	3509-3512	was	_
22-8	3513-3515	25	_
22-9	3516-3521	years	_
22-10	3522-3523	[	_
22-11	3524-3528	mean	_
22-12	3529-3530	=	_
22-13	3531-3535	28.3	_
22-14	3536-3537	,	_
22-15	3538-3546	standard	_
22-16	3547-3556	deviation	_
22-17	3557-3558	(	_
22-18	3559-3561	SD	_
22-19	3562-3563	)	_
22-20	3564-3565	=	_
22-21	3566-3570	12.6	_
22-22	3571-3572	]	_
22-23	3573-3574	.	_

23-1	3575-3585	Fifty-five	_
23-2	3586-3593	percent	_
23-3	3594-3596	of	_
23-4	3597-3607	alcoholics	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
23-5	3608-3611	and	_
23-6	3612-3613	0	_
23-7	3614-3621	percent	_
23-8	3622-3624	of	_
23-9	3625-3633	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
23-10	3634-3637	met	_
23-11	3638-3644	DSM-IV	_
23-12	3645-3653	criteria	_
23-13	3654-3657	for	_
23-14	3658-3661	any	_
23-15	3662-3666	type	_
23-16	3667-3669	of	_
23-17	3670-3674	drug	_
23-18	3675-3685	dependence	_
23-19	3686-3688	or	_
23-20	3689-3694	abuse	_
23-21	3695-3696	.	_

24-1	3697-3700	The	_
24-2	3701-3705	most	_
24-3	3706-3712	common	_
24-4	3713-3717	type	_
24-5	3718-3720	of	_
24-6	3721-3725	drug	_
24-7	3726-3736	dependence	_
24-8	3737-3739	or	_
24-9	3740-3745	abuse	_
24-10	3746-3751	among	_
24-11	3752-3762	alcoholics	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
24-12	3763-3766	was	_
24-13	3767-3774	cocaine	_
24-14	3775-3776	(	_
24-15	3777-3785	endorsed	_
24-16	3786-3788	by	_
24-17	3789-3791	38	_
24-18	3792-3799	percent	_
24-19	3800-3802	of	_
24-20	3803-3813	alcoholics	_
24-21	3814-3815	)	_
24-22	3816-3817	,	_
24-23	3818-3821	and	_
24-24	3822-3825	the	_
24-25	3826-3832	median	_
24-26	3833-3839	number	_
24-27	3840-3842	of	_
24-28	3843-3848	weeks	_
24-29	3849-3854	since	_
24-30	3855-3859	last	_
24-31	3860-3867	meeting	_
24-32	3868-3872	drug	_
24-33	3873-3883	dependence	_
24-34	3884-3892	criteria	_
24-35	3893-3896	was	_
24-36	3897-3900	406	_
24-37	3901-3906	weeks	_
24-38	3907-3908	(	_
24-39	3909-3913	mean	_
24-40	3914-3915	=	_
24-41	3916-3919	646	_
24-42	3920-3925	weeks	_
24-43	3926-3927	,	_
24-44	3928-3930	SD	_
24-45	3931-3932	=	_
24-46	3933-3936	557	_
24-47	3937-3942	weeks	_
24-48	3943-3944	)	_
24-49	3945-3946	.	_

25-1	3947-3960	Significantly	_
25-2	3961-3965	more	_
25-3	3966-3976	alcoholics	_
25-4	3977-3980	met	_
25-5	3981-3987	DSM-IV	_
25-6	3988-3996	criteria	_
25-7	3997-4000	for	_
25-8	4001-4009	nicotine	_
25-9	4010-4020	dependence	_
25-10	4021-4022	(	_
25-11	4023-4024	n	_
25-12	4025-4026	=	_
25-13	4027-4029	41	_
25-14	4030-4031	)	_
25-15	4032-4036	than	_
25-16	4037-4045	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
25-17	4046-4047	(	_
25-18	4048-4049	n	_
25-19	4050-4051	=	_
25-20	4052-4053	6	_
25-21	4054-4055	)	_
25-22	4056-4057	,	_
25-23	4058-4060	χ2	_
25-24	4061-4062	(	_
25-25	4063-4064	1	_
25-26	4065-4066	)	_
25-27	4067-4068	=	_
25-28	4069-4074	43.33	_
25-29	4075-4076	,	_
25-30	4077-4078	P	_
25-31	4079-4080	<	_
25-32	4081-4086	0.001	_
25-33	4087-4088	(	_
25-34	4089-4095	Fisher	_
25-35	4096-4097	’	_
25-36	4098-4099	s	_
25-37	4100-4105	exact	_
25-38	4106-4110	test	_
25-39	4111-4112	)	_
25-40	4113-4114	.	_

26-1	4115-4129	Questionnaires	_
26-2	4130-4131	,	_
26-3	4132-4150	neuropsychological	_
26-4	4151-4156	tests	http://maven.renci.org/NeuroBridge/neurobridge#Impedance
26-5	4157-4160	and	_
26-6	4161-4169	clinical	_
26-7	4170-4181	assessments	_
26-8	4182-4186	were	_
26-9	4187-4192	given	_
26-10	4193-4199	before	_
26-11	4200-4202	or	_
26-12	4203-4208	after	_
26-13	4209-4217	scanning	_
26-14	4218-4221	and	_
26-15	4222-4230	included	_
26-16	4231-4244	socioeconomic	_
26-17	4245-4251	status	_
26-18	4252-4253	,	_
26-19	4254-4261	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
26-20	4262-4265	use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
26-21	4266-4275	disorders	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
26-22	4276-4290	identification	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
26-23	4291-4295	test	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
26-24	4296-4297	(	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
26-25	4298-4303	AUDIT	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
26-26	4304-4305	)	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseDisordersIdentificationTest
26-27	4306-4307	,	_
26-28	4308-4312	Beck	http://maven.renci.org/NeuroBridge/neurobridge#BeckDepressionInventory
26-29	4313-4323	Depression	http://maven.renci.org/NeuroBridge/neurobridge#BeckDepressionInventory
26-30	4324-4333	Inventory	http://maven.renci.org/NeuroBridge/neurobridge#BeckDepressionInventory
26-31	4334-4335	(	http://maven.renci.org/NeuroBridge/neurobridge#BeckDepressionInventory
26-32	4336-4342	BDI-II	http://maven.renci.org/NeuroBridge/neurobridge#BeckDepressionInventory
26-33	4343-4344	)	http://maven.renci.org/NeuroBridge/neurobridge#BeckDepressionInventory
26-34	4345-4346	,	_
26-35	4347-4355	Wechsler	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
26-36	4356-4360	Test	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
26-37	4361-4363	of	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
26-38	4364-4369	Adult	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
26-39	4370-4377	Reading	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
26-40	4378-4379	(	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
26-41	4380-4384	WTAR	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
26-42	4385-4386	)	http://maven.renci.org/NeuroBridge/neurobridge#NationalAdultReadingTest
26-43	4387-4388	,	_
26-44	4389-4397	Wechsler	http://maven.renci.org/NeuroBridge/neurobridge#Revised
26-45	4398-4404	Memory	http://maven.renci.org/NeuroBridge/neurobridge#Revised
26-46	4405-4418	Scale-Revised	http://maven.renci.org/NeuroBridge/neurobridge#Revised
26-47	4419-4420	(	http://maven.renci.org/NeuroBridge/neurobridge#Revised
26-48	4421-4426	WMS-R	http://maven.renci.org/NeuroBridge/neurobridge#Revised
26-49	4427-4428	)	http://maven.renci.org/NeuroBridge/neurobridge#Revised
26-50	4429-4430	,	_
26-51	4431-4441	California	http://maven.renci.org/NeuroBridge/neurobridge#II
26-52	4442-4448	Verbal	http://maven.renci.org/NeuroBridge/neurobridge#II
26-53	4449-4457	Learning	http://maven.renci.org/NeuroBridge/neurobridge#II
26-54	4458-4465	Test-II	http://maven.renci.org/NeuroBridge/neurobridge#II
26-55	4466-4467	(	http://maven.renci.org/NeuroBridge/neurobridge#II
26-56	4468-4475	CVLT-II	http://maven.renci.org/NeuroBridge/neurobridge#II
26-57	4476-4477	)	http://maven.renci.org/NeuroBridge/neurobridge#II
26-58	4478-4481	and	_
26-59	4482-4485	the	_
26-60	4486-4491	Digit	_
26-61	4492-4498	Symbol	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
26-62	4499-4506	subtest	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
26-63	4507-4509	of	_
26-64	4510-4513	the	_
26-65	4514-4522	Wechsler	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
26-66	4523-4528	Adult	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
26-67	4529-4541	Intelligence	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
26-68	4542-4555	Scale-Revised	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
26-69	4556-4557	(	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
26-70	4558-4564	WAIS-R	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
26-71	4565-4566	)	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
26-72	4567-4568	.	_

27-1	4569-4576	Imaging	_
27-2	4577-4581	data	_
27-3	4582-4593	acquisition	_
27-4	4594-4597	All	_
27-5	4598-4611	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
27-6	4612-4616	data	_
27-7	4617-4625	required	_
27-8	4626-4634	subjects	_
27-9	4635-4637	to	_
27-10	4638-4642	have	_
27-11	4643-4648	their	_
27-12	4649-4653	eyes	_
27-13	4654-4658	open	_
27-14	4659-4664	while	_
27-15	4665-4667	in	_
27-16	4668-4671	one	_
27-17	4672-4674	of	_
27-18	4675-4678	two	_
27-19	4679-4686	General	_
27-20	4687-4695	Electric	_
27-21	4696-4697	(	_
27-22	4698-4704	Boston	_
27-23	4705-4706	,	_
27-24	4707-4709	MA	_
27-25	4710-4711	,	_
27-26	4712-4715	USA	_
27-27	4716-4717	)	_
27-28	4718-4723	human	_
27-29	4724-4727	MRI	_
27-30	4728-4735	systems	_
27-31	4736-4737	(	_
27-32	4738-4740	3T	_
27-33	4741-4746	Signa	_
27-34	4747-4750	and	_
27-35	4751-4756	MR750	_
27-36	4757-4758	)	_
27-37	4759-4763	with	_
27-38	4764-4766	an	_
27-39	4767-4780	eight-channel	_
27-40	4781-4785	head	_
27-41	4786-4790	coil	_
27-42	4791-4794	and	_
27-43	4795-4798	the	_
27-44	4799-4803	same	_
27-45	4804-4815	acquisition	_
27-46	4816-4826	parameters	_
27-47	4827-4828	.	_

28-1	4829-4832	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
28-2	4833-4840	scanner	_
28-3	4841-4847	system	_
28-4	4848-4851	was	_
28-5	4852-4859	modeled	_
28-6	4860-4862	as	_
28-7	4863-4864	a	_
28-8	4865-4874	covariate	_
28-9	4875-4877	in	_
28-10	4878-4879	a	_
28-11	4880-4888	separate	_
28-12	4889-4899	group-ALFF	_
28-13	4900-4908	analysis	_
28-14	4909-4910	.	_

29-1	4911-4914	Ear	_
29-2	4915-4920	plugs	_
29-3	4921-4924	and	_
29-4	4925-4941	noise-cancelling	_
29-5	4942-4952	headphones	_
29-6	4953-4957	were	_
29-7	4958-4962	used	_
29-8	4963-4965	to	_
29-9	4966-4970	help	_
29-10	4971-4977	reduce	_
29-11	4978-4981	the	_
29-12	4982-4987	noise	_
29-13	4988-4992	from	_
29-14	4993-4996	the	_
29-15	4997-5004	scanner	_
29-16	5005-5006	.	_

30-1	5007-5010	The	_
30-2	5011-5017	number	_
30-3	5018-5020	of	_
30-4	5021-5029	subjects	_
30-5	5030-5037	scanned	_
30-6	5038-5040	by	_
30-7	5041-5045	each	_
30-8	5046-5053	scanner	_
30-9	5054-5056	is	_
30-10	5057-5062	shown	_
30-11	5063-5065	in	_
30-12	5066-5071	Table	_
30-13	5072-5073	1	_
30-14	5074-5075	.	_

31-1	5076-5087	Whole-brain	_
31-2	5088-5095	rs-fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
31-3	5096-5100	data	_
31-4	5101-5105	were	_
31-5	5106-5114	acquired	_
31-6	5115-5119	with	_
31-7	5120-5121	a	_
31-8	5122-5124	T2	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
31-9	5125-5126	*	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
31-10	5127-5135	weighted	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
31-11	5136-5144	gradient	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
31-12	5145-5156	echo-planar	http://maven.renci.org/NeuroBridge/neurobridge#T2WeightedImaging
31-13	5157-5162	pulse	_
31-14	5163-5171	sequence	_
31-15	5172-5173	[	_
31-16	5174-5176	2D	_
31-17	5177-5182	axial	_
31-18	5183-5184	;	_
31-19	5185-5189	echo	_
31-20	5190-5194	time	_
31-21	5195-5196	(	_
31-22	5197-5199	TE	_
31-23	5200-5201	)	_
31-24	5202-5203	=	_
31-25	5204-5206	30	_
31-26	5207-5209	ms	_
31-27	5210-5211	;	_
31-28	5212-5222	repetition	_
31-29	5223-5227	time	_
31-30	5228-5229	(	_
31-31	5230-5232	TR	_
31-32	5233-5234	)	_
31-33	5235-5236	=	_
31-34	5237-5241	2200	_
31-35	5242-5244	ms	_
31-36	5245-5246	;	_
31-37	5247-5251	flip	_
31-38	5252-5257	angle	_
31-39	5258-5259	=	_
31-40	5260-5263	90°	_
31-41	5264-5265	;	_
31-42	5266-5271	field	_
31-43	5272-5274	of	_
31-44	5275-5279	view	_
31-45	5280-5281	(	_
31-46	5282-5285	FOV	_
31-47	5286-5287	)	_
31-48	5288-5289	=	_
31-49	5290-5293	240	_
31-50	5294-5296	mm	_
31-51	5297-5298	;	_
31-52	5299-5307	in-plane	_
31-53	5308-5318	resolution	_
31-54	5319-5320	=	_
31-55	5321-5325	3.75	_
31-56	5326-5328	mm	_
31-57	5329-5330	;	_
31-58	5331-5337	matrix	_
31-59	5338-5339	=	_
31-60	5340-5342	64	_
31-61	5343-5344	×	_
31-62	5345-5347	64	_
31-63	5348-5349	;	_
31-64	5350-5355	slice	_
31-65	5356-5365	thickness	_
31-66	5366-5367	=	_
31-67	5368-5369	5	_
31-68	5370-5372	mm	_
31-69	5373-5374	;	_
31-70	5375-5379	skip	_
31-71	5380-5381	=	_
31-72	5382-5383	0	_
31-73	5384-5386	mm	_
31-74	5387-5388	;	_
31-75	5389-5391	36	_
31-76	5392-5398	slices	_
31-77	5399-5400	]	_
31-78	5401-5402	.	_

32-1	5403-5404	A	_
32-2	5405-5414	dual-echo	http://maven.renci.org/NeuroBridge/neurobridge#DualEnergyXRayAbsorptiometry
32-3	5415-5419	fast	http://maven.renci.org/NeuroBridge/neurobridge#DualEnergyXRayAbsorptiometry
32-4	5420-5429	spin-echo	http://maven.renci.org/NeuroBridge/neurobridge#DualEnergyXRayAbsorptiometry
32-5	5430-5434	scan	http://maven.renci.org/NeuroBridge/neurobridge#DualEnergyXRayAbsorptiometry
32-6	5435-5438	was	_
32-7	5439-5447	obtained	_
32-8	5448-5451	for	_
32-9	5452-5459	spatial	_
32-10	5460-5472	registration	_
32-11	5473-5478	using	_
32-12	5479-5482	the	_
32-13	5483-5492	following	_
32-14	5493-5503	parameters	_
32-15	5504-5505	:	_
32-16	5506-5508	2D	_
32-17	5509-5514	axial	_
32-18	5515-5516	;	_
32-19	5517-5519	TE	_
32-20	5520-5521	=	_
32-21	5522-5524	17	_
32-22	5525-5526	/	_
32-23	5527-5530	102	_
32-24	5531-5533	ms	_
32-25	5534-5535	;	_
32-26	5536-5538	TR	_
32-27	5539-5540	=	_
32-28	5541-5545	5000	_
32-29	5546-5548	ms	_
32-30	5549-5550	;	_
32-31	5551-5555	flip	_
32-32	5556-5561	angle	_
32-33	5562-5563	=	_
32-34	5564-5567	90°	_
32-35	5568-5569	;	_
32-36	5570-5573	FOV	_
32-37	5574-5575	=	_
32-38	5576-5579	240	_
32-39	5580-5582	mm	_
32-40	5583-5584	;	_
32-41	5585-5591	matrix	_
32-42	5592-5593	=	_
32-43	5594-5597	256	_
32-44	5598-5599	×	_
32-45	5600-5603	256	_
32-46	5604-5605	;	_
32-47	5606-5611	slice	_
32-48	5612-5621	thickness	_
32-49	5622-5623	=	_
32-50	5624-5625	5	_
32-51	5626-5628	mm	_
32-52	5629-5630	;	_
32-53	5631-5635	skip	_
32-54	5636-5637	=	_
32-55	5638-5639	0	_
32-56	5640-5642	mm	_
32-57	5643-5644	;	_
32-58	5645-5647	36	_
32-59	5648-5654	slices	_
32-60	5655-5656	.	_

33-1	5657-5659	To	_
33-2	5660-5667	correct	_
33-3	5668-5671	for	_
33-4	5672-5679	spatial	_
33-5	5680-5691	distortions	_
33-6	5692-5694	in	_
33-7	5695-5698	the	_
33-8	5699-5709	echoplanar	_
33-9	5710-5716	images	_
33-10	5717-5718	,	_
33-11	5719-5721	we	_
33-12	5722-5730	acquired	_
33-13	5731-5732	a	_
33-14	5733-5738	field	_
33-15	5739-5742	map	_
33-16	5743-5747	with	_
33-17	5748-5749	a	_
33-18	5750-5766	gradientrecalled	_
33-19	5767-5771	echo	_
33-20	5772-5780	sequence	_
33-21	5781-5785	pair	_
33-22	5786-5787	(	_
33-23	5788-5790	TE	_
33-24	5791-5792	=	_
33-25	5793-5796	3/5	_
33-26	5797-5799	ms	_
33-27	5800-5801	;	_
33-28	5802-5804	TR	_
33-29	5805-5806	=	_
33-30	5807-5810	460	_
33-31	5811-5813	ms	_
33-32	5814-5815	,	_
33-33	5816-5821	slice	_
33-34	5822-5831	thickness	_
33-35	5832-5833	=	_
33-36	5834-5835	5	_
33-37	5836-5838	mm	_
33-38	5839-5840	;	_
33-39	5841-5845	skip	_
33-40	5846-5847	=	_
33-41	5848-5849	0	_
33-42	5850-5852	mm	_
33-43	5853-5854	;	_
33-44	5855-5857	36	_
33-45	5858-5864	slices	_
33-46	5865-5866	)	_
33-47	5867-5868	.	_

34-1	5869-5874	Image	_
34-2	5875-5888	preprocessing	_
34-3	5889-5896	Rs-fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
34-4	5897-5901	data	_
34-5	5902-5915	preprocessing	_
34-6	5916-5919	was	_
34-7	5920-5929	performed	_
34-8	5930-5935	using	_
34-9	5936-5947	STATISTICAL	_
34-10	5948-5958	PARAMETRIC	_
34-11	5959-5966	MAPPING	_
34-12	5967-5968	8	_
34-13	5969-5970	(	_
34-14	5971-5975	SPM8	_
34-15	5976-5977	)	_
34-16	5978-5986	software	_
34-17	5987-5995	Wellcome	_
34-18	5996-6001	Trust	_
34-19	6002-6008	Centre	_
34-20	6009-6012	for	_
34-21	6013-6025	Neuroimaging	_
34-22	6026-6027	;	_
34-23	6028-6034	London	_
34-24	6035-6036	,	_
34-25	6037-6039	UK	_
34-26	6040-6041	;	_
34-27	6042-6046	http	_
34-28	6047-6048	:	_
34-29	6049-6091	//www.fil.ion.ucl.ac.uk/spm/software/spm8/	_
34-30	6092-6093	)	_
34-31	6094-6095	.	_

35-1	6096-6102	Images	_
35-2	6103-6107	were	_
35-3	6108-6113	first	_
35-4	6114-6123	converted	_
35-5	6124-6128	from	_
35-6	6129-6134	DICOM	_
35-7	6135-6139	into	_
35-8	6140-6145	NIFTI	_
35-9	6146-6152	format	_
35-10	6153-6161	followed	_
35-11	6162-6164	by	_
35-12	6165-6172	spatial	_
35-13	6173-6184	realignment	_
35-14	6185-6188	and	_
35-15	6189-6198	unwarping	_
35-16	6199-6201	of	_
35-17	6202-6212	echoplanar	_
35-18	6213-6219	images	_
35-19	6220-6222	to	_
35-20	6223-6230	correct	_
35-21	6231-6234	for	_
35-22	6235-6244	geometric	_
35-23	6245-6255	distortion	_
35-24	6256-6259	and	_
35-25	6260-6264	head	_
35-26	6265-6271	motion	_
35-27	6272-6273	.	_

36-1	6274-6277	For	_
36-2	6278-6285	further	_
36-3	6286-6294	analysis	_
36-4	6295-6296	,	_
36-5	6297-6305	datasets	_
36-6	6306-6308	of	_
36-7	6309-6312	the	_
36-8	6313-6316	112	_
36-9	6317-6325	subjects	_
36-10	6326-6329	had	_
36-11	6330-6332	to	_
36-12	6333-6337	have	_
36-13	6338-6344	motion	_
36-14	6345-6349	less	_
36-15	6350-6354	than	_
36-16	6355-6361	1.7-mm	_
36-17	6362-6373	translation	_
36-18	6374-6376	in	_
36-19	6377-6378	x	_
36-20	6379-6380	,	_
36-21	6381-6382	y	_
36-22	6383-6386	and	_
36-23	6387-6388	z	_
36-24	6389-6392	and	_
36-25	6393-6396	not	_
36-26	6397-6403	exceed	_
36-27	6404-6406	2°	_
36-28	6407-6415	rotation	_
36-29	6416-6418	in	_
36-30	6419-6422	all	_
36-31	6423-6428	three	_
36-32	6429-6439	directions	_
36-33	6440-6441	.	_

37-1	6442-6452	Frame-wise	_
37-2	6453-6465	displacement	_
37-3	6466-6472	values	_
37-4	6473-6477	were	_
37-5	6478-6488	calculated	_
37-6	6489-6492	for	_
37-7	6493-6503	individual	_
37-8	6504-6509	scans	_
37-9	6510-6511	,	_
37-10	6512-6515	the	_
37-11	6516-6523	maximum	_
37-12	6524-6536	displacement	_
37-13	6537-6540	was	_
37-14	6541-6545	1.88	_
37-15	6546-6549	and	_
37-16	6550-6553	the	_
37-17	6554-6561	largest	_
37-18	6562-6572	individual	_
37-19	6573-6577	mean	_
37-20	6578-6590	displacement	_
37-21	6591-6596	value	_
37-22	6597-6600	was	_
37-23	6601-6605	0.27	_
37-24	6606-6607	.	_

38-1	6608-6613	Given	_
38-2	6614-6617	the	_
38-3	6618-6622	lack	_
38-4	6623-6625	of	_
38-5	6626-6635	consensus	_
38-6	6636-6638	in	_
38-7	6639-6642	the	_
38-8	6643-6653	literature	_
38-9	6654-6656	on	_
38-10	6657-6663	motion	_
38-11	6664-6674	thresholds	_
38-12	6675-6678	for	_
38-13	6679-6683	scan	_
38-14	6684-6693	exclusion	_
38-15	6694-6695	,	_
38-16	6696-6698	we	_
38-17	6699-6707	followed	_
38-18	6708-6716	previous	_
38-19	6717-6732	recommendations	_
38-20	6733-6734	(	_
38-21	6735-6739	e.g.	_
38-22	6740-6741	,	_
38-23	6742-6743	)	_
38-24	6744-6745	.	_

39-1	6746-6749	The	_
39-2	6750-6754	mean	_
39-3	6755-6763	unwarped	_
39-4	6764-6774	functional	_
39-5	6775-6781	images	_
39-6	6782-6786	were	_
39-7	6787-6800	co-registered	_
39-8	6801-6805	with	_
39-9	6806-6809	the	_
39-10	6810-6814	fast	_
39-11	6815-6824	spin-echo	_
39-12	6825-6835	anatomical	_
39-13	6836-6842	images	_
39-14	6843-6846	for	_
39-15	6847-6851	each	_
39-16	6852-6859	subject	_
39-17	6860-6861	.	_

40-1	6862-6865	The	_
40-2	6866-6874	unwarped	_
40-3	6875-6885	functional	_
40-4	6886-6889	and	_
40-5	6890-6900	anatomical	_
40-6	6901-6907	images	_
40-7	6908-6912	were	_
40-8	6913-6917	then	_
40-9	6918-6928	normalized	_
40-10	6929-6931	to	_
40-11	6932-6935	the	_
40-12	6936-6944	standard	_
40-13	6945-6953	Montreal	_
40-14	6954-6966	Neurological	_
40-15	6967-6976	Institute	_
40-16	6977-6982	space	_
40-17	6983-6986	and	_
40-18	6987-6996	resampled	_
40-19	6997-6999	to	_
40-20	7000-7001	a	_
40-21	7002-7007	voxel	_
40-22	7008-7012	size	_
40-23	7013-7015	of	_
40-24	7016-7017	2	_
40-25	7018-7019	×	_
40-26	7020-7021	2	_
40-27	7022-7023	×	_
40-28	7024-7025	2	_
40-29	7026-7028	mm	_
40-30	7029-7030	.	_

41-1	7031-7032	A	_
41-2	7033-7041	Gaussian	_
41-3	7042-7048	kernel	_
41-4	7049-7051	of	_
41-5	7052-7056	8-mm	_
41-6	7057-7067	full-width	_
41-7	7068-7070	at	_
41-8	7071-7083	half-maximum	_
41-9	7084-7087	was	_
41-10	7088-7095	applied	_
41-11	7096-7098	to	_
41-12	7099-7102	the	_
41-13	7103-7113	normalized	_
41-14	7114-7124	functional	_
41-15	7125-7131	images	_
41-16	7132-7133	.	_

42-1	7134-7138	ALFF	_
42-2	7139-7150	calculation	_
42-3	7151-7163	Preprocessed	_
42-4	7164-7174	functional	_
42-5	7175-7181	images	_
42-6	7182-7186	were	_
42-7	7187-7195	imported	_
42-8	7196-7200	into	_
42-9	7201-7207	DPARSF	_
42-10	7208-7211	4.0	_
42-11	7212-7220	Advanced	_
42-12	7221-7228	toolbox	_
42-13	7229-7230	(	_
42-14	7231-7235	Data	_
42-15	7236-7246	Processing	_
42-16	7247-7248	&	_
42-17	7249-7257	Analysis	_
42-18	7258-7260	of	_
42-19	7261-7266	Brain	_
42-20	7267-7274	Imaging	_
42-21	7275-7276	;	_
42-22	7277-7281	http	_
42-23	7282-7283	:	_
42-24	7284-7301	//rfmri.org/dpabi	_
42-25	7302-7303	;	_
42-26	7304-7311	ChaoGan	_
42-27	7312-7315	Yan	_
42-28	7316-7317	,	_
42-29	7318-7321	New	_
42-30	7322-7326	York	_
42-31	7327-7328	,	_
42-32	7329-7331	NY	_
42-33	7332-7333	,	_
42-34	7334-7337	USA	_
42-35	7338-7339	)	_
42-36	7340-7343	for	_
42-37	7344-7348	ALFF	_
42-38	7349-7360	calculation	_
42-39	7361-7362	.	_

43-1	7363-7366	For	_
43-2	7367-7370	the	_
43-3	7371-7380	frequency	_
43-4	7381-7386	power	_
43-5	7387-7395	spectrum	_
43-6	7396-7398	to	_
43-7	7399-7401	be	_
43-8	7402-7410	obtained	_
43-9	7411-7412	,	_
43-10	7413-7416	the	_
43-11	7417-7421	time	_
43-12	7422-7428	series	_
43-13	7429-7431	of	_
43-14	7432-7436	each	_
43-15	7437-7442	voxel	_
43-16	7443-7449	within	_
43-17	7450-7453	the	_
43-18	7454-7464	individual	_
43-19	7465-7475	functional	_
43-20	7476-7482	images	_
43-21	7483-7486	was	_
43-22	7487-7498	transformed	_
43-23	7499-7503	into	_
43-24	7504-7507	the	_
43-25	7508-7517	frequency	_
43-26	7518-7524	domain	_
43-27	7525-7530	using	_
43-28	7531-7532	a	_
43-29	7533-7537	fast	_
43-30	7538-7545	Fourier	_
43-31	7546-7555	transform	_
43-32	7556-7557	.	_

44-1	7558-7561	The	_
44-2	7562-7566	full	_
44-3	7567-7576	frequency	_
44-4	7577-7582	range	_
44-5	7583-7586	was	_
44-6	7587-7591	then	_
44-7	7592-7599	divided	_
44-8	7600-7604	into	_
44-9	7605-7610	three	_
44-10	7611-7620	frequency	_
44-11	7621-7629	bands—LF	_
44-12	7630-7631	(	_
44-13	7632-7642	0.01–0.027	_
44-14	7643-7645	Hz	_
44-15	7646-7647	)	_
44-16	7648-7649	,	_
44-17	7650-7652	MF	_
44-18	7653-7654	(	_
44-19	7655-7666	0.027–0.073	_
44-20	7667-7669	Hz	_
44-21	7670-7671	)	_
44-22	7672-7675	and	_
44-23	7676-7678	HF	_
44-24	7679-7680	(	_
44-25	7681-7692	0.073–0.198	_
44-26	7693-7695	Hz	_
44-27	7696-7697	)	_
44-28	7698-7702	—for	_
44-29	7703-7710	further	_
44-30	7711-7715	ALFF	_
44-31	7716-7721	value	_
44-32	7722-7733	calculation	_
44-33	7734-7735	.	_

45-1	7736-7739	For	_
45-2	7740-7741	a	_
45-3	7742-7747	given	_
45-4	7748-7753	voxel	_
45-5	7754-7755	,	_
45-6	7756-7759	the	_
45-7	7760-7768	absolute	_
45-8	7769-7774	value	_
45-9	7775-7777	of	_
45-10	7778-7781	the	_
45-11	7782-7791	frequency	_
45-12	7792-7797	power	_
45-13	7798-7806	spectrum	_
45-14	7807-7810	was	_
45-15	7811-7819	averaged	_
45-16	7820-7826	across	_
45-17	7827-7830	the	_
45-18	7831-7841	predefined	_
45-19	7842-7851	frequency	_
45-20	7852-7856	band	_
45-21	7857-7858	.	_

46-1	7859-7863	Note	_
46-2	7864-7868	that	_
46-3	7869-7872	the	_
46-4	7873-7882	scrubbing	_
46-5	7883-7891	approach	_
46-6	7892-7893	,	_
46-7	7894-7902	endorsed	_
46-8	7903-7905	to	_
46-9	7906-7913	correct	_
46-10	7914-7917	for	_
46-11	7918-7925	outlier	_
46-12	7926-7932	frames	_
46-13	7933-7935	in	_
46-14	7936-7949	resting-state	_
46-15	7950-7954	time	_
46-16	7955-7961	series	_
46-17	7962-7970	analysis	_
46-18	7971-7972	,	_
46-19	7973-7975	is	_
46-20	7976-7979	not	_
46-21	7980-7991	recommended	_
46-22	7992-7995	for	_
46-23	7996-8000	ALFF	_
46-24	8001-8009	analysis	_
46-25	8010-8011	,	_
46-26	8012-8019	because	_
46-27	8020-8023	the	_
46-28	8024-8028	ALFF	_
46-29	8029-8040	calculation	_
46-30	8041-8043	is	_
46-31	8044-8049	based	_
46-32	8050-8052	on	_
46-33	8053-8057	fast	_
46-34	8058-8065	Fourier	_
46-35	8066-8075	transform	_
46-36	8076-8077	,	_
46-37	8078-8083	which	_
46-38	8084-8087	can	_
46-39	8088-8091	not	_
46-40	8092-8094	be	_
46-41	8095-8102	applied	_
46-42	8103-8105	to	_
46-43	8106-8114	scrubbed	_
46-44	8115-8119	data	_
46-45	8120-8125	owing	_
46-46	8126-8128	to	_
46-47	8129-8139	alteration	_
46-48	8140-8142	of	_
46-49	8143-8146	its	_
46-50	8147-8155	temporal	_
46-51	8156-8165	structure	_
46-52	8166-8168	by	_
46-53	8169-8176	removal	_
46-54	8177-8179	of	_
46-55	8180-8186	frames	_
46-56	8187-8188	.	_

47-1	8189-8196	Instead	_
47-2	8197-8198	,	_
47-3	8199-8201	we	_
47-4	8202-8206	used	_
47-5	8207-8219	standardized	_
47-6	8220-8225	zALFF	_
47-7	8226-8237	individuals	_
47-8	8238-8242	maps	_
47-9	8243-8244	,	_
47-10	8245-8247	on	_
47-11	8248-8251	the	_
47-12	8252-8257	basis	_
47-13	8258-8260	of	_
47-14	8261-8269	evidence	_
47-15	8270-8277	showing	_
47-16	8278-8285	reduced	_
47-17	8286-8292	motion	_
47-18	8293-8300	effects	_
47-19	8301-8303	at	_
47-20	8304-8314	individual	_
47-21	8315-8320	level	_
47-22	8321-8324	and	_
47-23	8325-8334	increased	_
47-24	8335-8346	test–retest	_
47-25	8347-8358	reliability	_
47-26	8359-8363	with	_
47-27	8364-8381	Z-standardization	_
47-28	8382-8384	at	_
47-29	8385-8390	group	_
47-30	8391-8399	analyses	_
47-31	8400-8401	.	_

48-1	8402-8405	For	_
48-2	8406-8423	Z-standardization	_
48-3	8424-8425	,	_
48-4	8426-8428	we	_
48-5	8429-8439	normalized	_
48-6	8440-8443	the	_
48-7	8444-8448	ALFF	_
48-8	8449-8454	value	_
48-9	8455-8458	for	_
48-10	8459-8463	each	_
48-11	8464-8469	voxel	_
48-12	8470-8472	by	_
48-13	8473-8484	subtracting	_
48-14	8485-8488	the	_
48-15	8489-8495	global	_
48-16	8496-8500	mean	_
48-17	8501-8503	of	_
48-18	8504-8507	the	_
48-19	8508-8512	ALFF	_
48-20	8513-8518	value	_
48-21	8519-8520	,	_
48-22	8521-8524	and	_
48-23	8525-8529	then	_
48-24	8530-8533	the	_
48-25	8534-8539	value	_
48-26	8540-8543	was	_
48-27	8544-8551	divided	_
48-28	8552-8554	by	_
48-29	8555-8558	the	_
48-30	8559-8561	SD	_
48-31	8562-8563	.	_

49-1	8564-8566	In	_
49-2	8567-8575	addition	_
49-3	8576-8577	,	_
49-4	8578-8580	we	_
49-5	8581-8589	compared	_
49-6	8590-8593	the	_
49-7	8594-8608	non-normalized	_
49-8	8609-8613	ALFF	_
49-9	8614-8619	value	_
49-10	8620-8622	of	_
49-11	8623-8627	each	_
49-12	8628-8633	voxel	_
49-13	8634-8641	between	_
49-14	8642-8652	alcoholics	_
49-15	8653-8656	and	_
49-16	8657-8665	controls	_
49-17	8666-8667	.	_

50-1	8668-8673	There	_
50-2	8674-8677	was	_
50-3	8678-8680	no	_
50-4	8681-8692	significant	_
50-5	8693-8698	group	_
50-6	8699-8709	difference	_
50-7	8710-8712	in	_
50-8	8713-8716	the	_
50-9	8717-8731	non-normalized	_
50-10	8732-8736	ALFF	_
50-11	8737-8743	values	_
50-12	8744-8745	.	_

51-1	8746-8755	Therefore	_
51-2	8756-8757	,	_
51-3	8758-8769	significant	_
51-4	8770-8775	group	_
51-5	8776-8787	differences	_
51-6	8788-8790	in	_
51-7	8791-8801	normalized	_
51-8	8802-8806	ALFF	_
51-9	8807-8818	comparisons	_
51-10	8819-8822	can	_
51-11	8823-8826	not	_
51-12	8827-8829	be	_
51-13	8830-8833	due	_
51-14	8834-8836	to	_
51-15	8837-8846	different	_
51-16	8847-8853	global	_
51-17	8854-8859	means	_
51-18	8860-8867	between	_
51-19	8868-8878	alcoholics	_
51-20	8879-8882	and	_
51-21	8883-8891	controls	_
51-22	8892-8893	.	_

52-1	8894-8898	ALFF	_
52-2	8899-8907	analysis	_
52-3	8908-8916	modeling	_
52-4	8917-8927	Individual	_
52-5	8928-8940	standardized	_
52-6	8941-8945	ALFF	_
52-7	8946-8950	maps	_
52-8	8951-8955	were	_
52-9	8956-8967	implemented	_
52-10	8968-8970	in	_
52-11	8971-8972	a	_
52-12	8973-8987	full-factorial	_
52-13	8988-8996	analysis	_
52-14	8997-8999	of	_
52-15	9000-9010	covariance	_
52-16	9011-9013	in	_
52-17	9014-9018	SPM8	_
52-18	9019-9020	.	_

53-1	9021-9022	A	_
53-2	9023-9034	secondlevel	_
53-3	9035-9049	full-factorial	_
53-4	9050-9055	model	_
53-5	9056-9059	was	_
53-6	9060-9064	used	_
53-7	9065-9067	to	_
53-8	9068-9075	examine	_
53-9	9076-9079	the	_
53-10	9080-9084	ALFF	_
53-11	9085-9096	differences	_
53-12	9097-9104	between	_
53-13	9105-9108	the	_
53-14	9109-9114	three	_
53-15	9115-9125	predefined	_
53-16	9126-9135	frequency	_
53-17	9136-9141	bands	_
53-18	9142-9145	and	_
53-19	9146-9153	between	_
53-20	9154-9164	alcoholics	_
53-21	9165-9168	and	_
53-22	9169-9177	controls	_
53-23	9178-9180	in	_
53-24	9181-9185	each	_
53-25	9186-9188	of	_
53-26	9189-9192	the	_
53-27	9193-9198	three	_
53-28	9199-9207	specific	_
53-29	9208-9217	frequency	_
53-30	9218-9223	bands	_
53-31	9224-9225	.	_

54-1	9226-9237	Independent	_
54-2	9238-9244	groups	_
54-3	9245-9246	(	_
54-4	9247-9255	controls	_
54-5	9256-9259	and	_
54-6	9260-9270	alcoholics	_
54-7	9271-9272	)	_
54-8	9273-9276	and	_
54-9	9277-9286	dependent	_
54-10	9287-9296	frequency	_
54-11	9297-9302	bands	_
54-12	9303-9304	(	_
54-13	9305-9307	LF	_
54-14	9308-9309	,	_
54-15	9310-9312	MF	_
54-16	9313-9316	and	_
54-17	9317-9319	HF	_
54-18	9320-9321	)	_
54-19	9322-9326	were	_
54-20	9327-9334	modeled	_
54-21	9335-9337	as	_
54-22	9338-9345	factors	_
54-23	9346-9347	.	_

55-1	9348-9351	The	_
55-2	9352-9362	frame-wise	_
55-3	9363-9375	displacement	_
55-4	9376-9382	values	_
55-5	9383-9385	of	_
55-6	9386-9390	each	_
55-7	9391-9401	individual	_
55-8	9402-9406	were	_
55-9	9407-9417	calculated	_
55-10	9418-9420	by	_
55-11	9421-9430	ArtRepair	_
55-12	9431-9435	tool	_
55-13	9436-9437	(	_
55-14	9438-9442	http	_
55-15	9443-9444	:	_
55-16	9445-9537	//cibsr.stanford.edu/tools/human-brain-project/artrepair-software/artrepairinstructions.html	_
55-17	9538-9539	)	_
55-18	9540-9545	using	_
55-19	9546-9549	the	_
55-20	9550-9553	six	_
55-21	9554-9565	realignment	_
55-22	9566-9576	parameters	_
55-23	9577-9578	.	_

56-1	9579-9589	Alcoholics	_
56-2	9590-9593	had	_
56-3	9594-9596	on	_
56-4	9597-9604	average	_
56-5	9605-9612	greater	_
56-6	9613-9627	frame-to-frame	_
56-7	9628-9640	displacement	_
56-8	9641-9647	values	_
56-9	9648-9652	than	_
56-10	9653-9661	controls	_
56-11	9662-9663	(	_
56-12	9664-9668	mean	_
56-13	9669-9681	displacement	_
56-14	9682-9683	:	_
56-15	9684-9692	controls	_
56-16	9693-9698	0.088	_
56-17	9699-9704	mm/TR	_
56-18	9705-9706	,	_
56-19	9707-9717	alcoholics	_
56-20	9718-9723	0.112	_
56-21	9724-9729	mm/TR	_
56-22	9730-9731	;	_
56-23	9732-9734	SD	_
56-24	9735-9736	,	_
56-25	9737-9745	controls	_
56-26	9746-9751	0.036	_
56-27	9752-9753	,	_
56-28	9754-9764	alcoholics	_
56-29	9765-9769	0.05	_
56-30	9770-9771	;	_
56-31	9772-9773	P	_
56-32	9774-9775	=	_
56-33	9776-9781	0.005	_
56-34	9782-9783	)	_
56-35	9784-9785	.	_

57-1	9786-9789	The	_
57-2	9790-9795	group	_
57-3	9796-9806	difference	_
57-4	9807-9809	in	_
57-5	9810-9820	frame-wise	_
57-6	9821-9833	displacement	_
57-7	9834-9837	was	_
57-8	9838-9843	small	_
57-9	9844-9847	and	_
57-10	9848-9856	remained	_
57-11	9857-9863	within	_
57-12	9864-9867	two	_
57-13	9868-9874	voxels	_
57-14	9875-9883	shifting	_
57-15	9884-9885	.	_

58-1	9886-9888	As	_
58-2	9889-9900	recommended	_
58-3	9901-9903	by	_
58-4	9904-9907	and	_
58-5	9908-9911	for	_
58-6	9912-9916	ALFF	_
58-7	9917-9922	group	_
58-8	9923-9933	statistics	_
58-9	9934-9936	to	_
58-10	9937-9944	control	_
58-11	9945-9948	for	_
58-12	9949-9957	residual	_
58-13	9958-9964	motion	_
58-14	9965-9967	in	_
58-15	9968-9971	the	_
58-16	9972-9984	second-level	_
58-17	9985-9990	group	_
58-18	9991-9999	analysis	_
58-19	10000-10001	,	_
58-20	10002-10004	we	_
58-21	10005-10012	modeled	_
58-22	10013-10016	the	_
58-23	10017-10027	individual	_
58-24	10028-10032	mean	_
58-25	10033-10043	frame-wise	_
58-26	10044-10056	displacement	_
58-27	10057-10059	in	_
58-28	10060-10068	addition	_
58-29	10069-10071	to	_
58-30	10072-10082	individual	_
58-31	10083-10086	age	_
58-32	10087-10088	,	_
58-33	10089-10092	and	_
58-34	10093-10097	type	_
58-35	10098-10100	of	_
58-36	10101-10103	GE	_
58-37	10104-10111	scanner	_
58-38	10112-10114	as	_
58-39	10115-10125	covariates	_
58-40	10126-10127	.	_

59-1	10128-10130	An	_
59-2	10131-10139	explicit	_
59-3	10140-10144	gray	_
59-4	10145-10151	matter	_
59-5	10152-10156	mask	_
59-6	10157-10164	created	_
59-7	10165-10167	on	_
59-8	10168-10171	the	_
59-9	10172-10177	basis	_
59-10	10178-10180	of	_
59-11	10181-10184	the	_
59-12	10185-10194	automated	_
59-13	10195-10205	anatomical	_
59-14	10206-10214	labeling	_
59-15	10215-10223	template	_
59-16	10224-10228	from	_
59-17	10229-10235	MRIcro	_
59-18	10236-10237	(	_
59-19	10238-10242	http	_
59-20	10243-10244	:	_
59-21	10245-10302	//www.mccauslandcenter.sc.edu/mricro/mricro/template.html	_
59-22	10303-10304	)	_
59-23	10305-10308	was	_
59-24	10309-10316	applied	_
59-25	10317-10319	to	_
59-26	10320-10323	the	_
59-27	10324-10329	model	_
59-28	10330-10331	.	_

60-1	10332-10349	Between-frequency	_
60-2	10350-10354	ALFF	_
60-3	10355-10363	analyses	_
60-4	10364-10368	With	_
60-5	10369-10377	previous	_
60-6	10378-10386	research	_
60-7	10387-10394	showing	_
60-8	10395-10399	ALFF	_
60-9	10400-10405	value	_
60-10	10406-10417	differences	_
60-11	10418-10424	across	_
60-12	10425-10434	frequency	_
60-13	10435-10440	bands	_
60-14	10441-10442	,	_
60-15	10443-10445	we	_
60-16	10446-10455	specified	_
60-17	10456-10459	SPM	_
60-18	10460-10471	t-contrasts	_
60-19	10472-10479	between	_
60-20	10480-10483	the	_
60-21	10484-10489	three	_
60-22	10490-10500	predefined	_
60-23	10501-10510	frequency	_
60-24	10511-10516	bands	_
60-25	10517-10519	to	_
60-26	10520-10527	examine	_
60-27	10528-10532	such	_
60-28	10533-10544	differences	_
60-29	10545-10547	in	_
60-30	10548-10552	ALFF	_
60-31	10553-10559	values	_
60-32	10560-10562	to	_
60-33	10563-10570	reflect	_
60-34	10571-10574	the	_
60-35	10575-10584	frequency	_
60-36	10585-10593	dynamics	_
60-37	10594-10595	(	_
60-38	10596-10598	HF	_
60-39	10599-10605	versus	_
60-40	10606-10608	MF	_
60-41	10609-10610	,	_
60-42	10611-10613	HF	_
60-43	10614-10620	versus	_
60-44	10621-10623	LF	_
60-45	10624-10627	and	_
60-46	10628-10630	MF	_
60-47	10631-10637	versus	_
60-48	10638-10640	LF	_
60-49	10641-10642	)	_
60-50	10643-10645	in	_
60-51	10646-10649	our	_
60-52	10650-10664	full-factorial	_
60-53	10665-10670	model	_
60-54	10671-10682	independent	_
60-55	10683-10685	of	_
60-56	10686-10691	group	_
60-57	10692-10703	differences	_
60-58	10704-10705	.	_

61-1	10706-10719	Between-group	_
61-2	10720-10724	ALFF	_
61-3	10725-10733	analyses	_
61-4	10734-10750	Group-difference	_
61-5	10751-10760	contrasts	_
61-6	10761-10765	were	_
61-7	10766-10775	specified	_
61-8	10776-10779	for	_
61-9	10780-10788	controls	_
61-10	10789-10790	>	_
61-11	10791-10801	alcoholics	_
61-12	10802-10805	and	_
61-13	10806-10816	alcoholics	_
61-14	10817-10818	>	_
61-15	10819-10827	controls	_
61-16	10828-10829	(	_
61-17	10830-10833	SPM	_
61-18	10834-10844	t-contrast	_
61-19	10845-10846	)	_
61-20	10847-10849	to	_
61-21	10850-10857	examine	_
61-22	10858-10865	whether	_
61-23	10866-10870	ALFF	_
61-24	10871-10877	values	_
61-25	10878-10881	for	_
61-26	10882-10886	each	_
61-27	10887-10897	predefined	_
61-28	10898-10907	frequency	_
61-29	10908-10912	band	_
61-30	10913-10917	were	_
61-31	10918-10925	greater	_
61-32	10926-10928	or	_
61-33	10929-10933	less	_
61-34	10934-10936	in	_
61-35	10937-10940	the	_
61-36	10941-10950	alcoholic	_
61-37	10951-10956	group	_
61-38	10957-10961	than	_
61-39	10962-10964	in	_
61-40	10965-10968	the	_
61-41	10969-10977	controls	_
61-42	10978-10979	.	_

62-1	10980-10991	Statistical	_
62-2	10992-11004	significance	_
62-3	11005-11008	for	_
62-4	11009-11013	ALFF	_
62-5	11014-11018	maps	_
62-6	11019-11021	To	_
62-7	11022-11029	account	_
62-8	11030-11033	for	_
62-9	11034-11042	multiple	_
62-10	11043-11054	comparisons	_
62-11	11055-11056	,	_
62-12	11057-11066	frequency	_
62-13	11067-11070	and	_
62-14	11071-11087	group-difference	_
62-15	11088-11095	results	_
62-16	11096-11100	were	_
62-17	11101-11110	corrected	_
62-18	11111-11113	by	_
62-19	11114-11124	performing	_
62-20	11125-11130	Monte	_
62-21	11131-11136	Carlo	_
62-22	11137-11147	simulation	_
62-23	11148-11151	for	_
62-24	11152-11162	two-tailed	_
62-25	11163-11174	comparisons	_
62-26	11175-11177	as	_
62-27	11178-11189	implemented	_
62-28	11190-11192	in	_
62-29	11193-11203	3dClustSim	_
62-30	11204-11205	(	_
62-31	11206-11211	https	_
62-32	11212-11213	:	_
62-33	11214-11275	//afni.nimh.nih.gov/pub/dist/doc/program_help/3dClustSim.html	_
62-34	11276-11277	;	_
62-35	11278-11284	Robert	_
62-36	11285-11287	W.	_
62-37	11288-11291	Cox	_
62-38	11292-11293	,	_
62-39	11294-11302	Bethesda	_
62-40	11303-11304	,	_
62-41	11305-11307	MD	_
62-42	11308-11309	,	_
62-43	11310-11313	USA	_
62-44	11314-11315	)	_
62-45	11316-11317	.	_

63-1	11318-11321	For	_
63-2	11322-11326	this	_
63-3	11327-11328	,	_
63-4	11329-11339	smoothness	_
63-5	11340-11350	parameters	_
63-6	11351-11353	of	_
63-7	11354-11357	the	_
63-8	11358-11366	residual	_
63-9	11367-11372	image	_
63-10	11373-11377	were	_
63-11	11378-11388	calculated	_
63-12	11389-11394	using	_
63-13	11395-11398	the	_
63-14	11399-11403	AFNI	_
63-15	11404-11411	program	_
63-16	11412-11419	3dFWHMx	_
63-17	11420-11421	(	_
63-18	11422-11427	https	_
63-19	11428-11429	:	_
63-20	11430-11488	//afni.nimh.nih.gov/pub/dist/doc/program_help/3dFWHMx.html	_
63-21	11489-11490	)	_
63-22	11491-11494	and	_
63-23	11495-11502	entered	_
63-24	11503-11507	into	_
63-25	11508-11518	3dClustSim	_
63-26	11519-11530	calculation	_
63-27	11531-11535	with	_
63-28	11536-11538	10	_
63-29	11539-11542	000	_
63-30	11543-11553	iterations	_
63-31	11554-11555	,	_
63-32	11556-11559	and	_
63-33	11560-11564	peak	_
63-34	11565-11574	threshold	_
63-35	11575-11586	probability	_
63-36	11587-11589	of	_
63-37	11590-11595	0.005	_
63-38	11596-11597	(	_
63-39	11598-11599	t	_
63-40	11600-11601	=	_
63-41	11602-11606	2.81	_
63-42	11607-11608	;	_
63-43	11609-11619	two-tailed	_
63-44	11620-11621	)	_
63-45	11622-11623	.	_

64-1	11624-11625	A	_
64-2	11626-11639	significantly	_
64-3	11640-11651	statistical	_
64-4	11652-11661	threshold	_
64-5	11662-11664	of	_
64-6	11665-11666	P	_
64-7	11667-11668	<	_
64-8	11669-11673	0.05	_
64-9	11674-11683	corrected	_
64-10	11684-11687	for	_
64-11	11688-11696	multiple	_
64-12	11697-11708	comparisons	_
64-13	11709-11717	required	_
64-14	11718-11719	a	_
64-15	11720-11730	contiguous	_
64-16	11731-11738	cluster	_
64-17	11739-11743	size	_
64-18	11744-11751	greater	_
64-19	11752-11756	than	_
64-20	11757-11760	131	_
64-21	11761-11767	voxels	_
64-22	11768-11769	.	_

65-1	11770-11774	This	_
65-2	11775-11786	statistical	_
65-3	11787-11794	cluster	_
65-4	11795-11804	threshold	_
65-5	11805-11808	for	_
65-6	11809-11817	multiple	_
65-7	11818-11828	comparison	_
65-8	11829-11839	correction	_
65-9	11840-11843	was	_
65-10	11844-11851	applied	_
65-11	11852-11854	to	_
65-12	11855-11858	all	_
65-13	11859-11871	second-level	_
65-14	11872-11879	t-tests	_
65-15	11880-11881	.	_

66-1	11882-11893	Statistical	_
66-2	11894-11902	analyses	_
66-3	11903-11905	of	_
66-4	11906-11911	group	_
66-5	11912-11927	characteristics	_
66-6	11928-11939	Independent	_
66-7	11940-11947	samples	_
66-8	11948-11955	t-tests	_
66-9	11956-11960	were	_
66-10	11961-11970	conducted	_
66-11	11971-11976	using	_
66-12	11977-11980	IBM	_
66-13	11981-11985	SPSS	_
66-14	11986-11990	v.23	_
66-15	11991-11992	(	_
66-16	11993-11999	Armonk	_
66-17	12000-12001	,	_
66-18	12002-12004	NY	_
66-19	12005-12006	,	_
66-20	12007-12010	USA	_
66-21	12011-12012	)	_
66-22	12013-12015	to	_
66-23	12016-12023	examine	_
66-24	12024-12029	group	_
66-25	12030-12041	differences	_
66-26	12042-12044	in	_
66-27	12045-12054	education	_
66-28	12055-12056	,	_
66-29	12057-12070	socioeconomic	_
66-30	12071-12077	status	_
66-31	12078-12079	,	_
66-32	12080-12088	lifetime	_
66-33	12089-12096	alcohol	_
66-34	12097-12108	consumption	_
66-35	12109-12110	,	_
66-36	12111-12115	days	_
66-37	12116-12121	since	_
66-38	12122-12126	last	_
66-39	12127-12132	drink	_
66-40	12133-12134	,	_
66-41	12135-12140	AUDIT	_
66-42	12141-12146	score	_
66-43	12147-12148	,	_
66-44	12149-12155	BDI-II	_
66-45	12156-12161	score	_
66-46	12162-12163	,	_
66-47	12164-12173	premorbid	_
66-48	12174-12176	IQ	_
66-49	12177-12178	(	_
66-50	12179-12183	WTAR	_
66-51	12184-12192	Standard	_
66-52	12193-12198	Score	_
66-53	12199-12200	)	_
66-54	12201-12202	,	_
66-55	12203-12210	logical	_
66-56	12211-12217	memory	_
66-57	12218-12219	(	_
66-58	12220-12225	WMS-R	_
66-59	12226-12231	total	_
66-60	12232-12235	raw	_
66-61	12236-12241	score	_
66-62	12242-12243	)	_
66-63	12244-12245	,	_
66-64	12246-12252	verbal	_
66-65	12253-12259	memory	_
66-66	12260-12261	(	_
66-67	12262-12269	CVLT-II	_
66-68	12270-12275	total	_
66-69	12276-12280	free	_
66-70	12281-12287	recall	_
66-71	12288-12293	score	_
66-72	12294-12295	)	_
66-73	12296-12299	and	_
66-74	12300-12311	graphomotor	_
66-75	12312-12317	speed	_
66-76	12318-12319	(	_
66-77	12320-12326	WAIS-R	_
66-78	12327-12332	Digit	_
66-79	12333-12339	Symbol	_
66-80	12340-12341	)	_
66-81	12342-12343	(	_
66-82	12344-12349	Table	_
66-83	12350-12351	1	_
66-84	12352-12353	)	_
66-85	12354-12355	.	_

67-1	12356-12359	The	_
67-2	12360-12378	neuropsychological	_
67-3	12379-12383	test	_
67-4	12384-12390	scores	_
67-5	12391-12392	(	_
67-6	12393-12402	premorbid	_
67-7	12403-12405	IQ	_
67-8	12406-12407	,	_
67-9	12408-12415	logical	_
67-10	12416-12422	memory	_
67-11	12423-12424	,	_
67-12	12425-12431	verbal	_
67-13	12432-12438	memory	_
67-14	12439-12442	and	_
67-15	12443-12454	graphomotor	_
67-16	12455-12460	speed	_
67-17	12461-12462	)	_
67-18	12463-12467	were	_
67-19	12468-12478	correlated	_
67-20	12479-12483	with	_
67-21	12484-12493	frequency	_
67-22	12494-12505	oscillation	_
67-23	12506-12511	power	_
67-24	12512-12513	(	_
67-25	12514-12523	extracted	_
67-26	12524-12528	ALFF	_
67-27	12529-12535	values	_
67-28	12536-12538	of	_
67-29	12539-12542	the	_
67-30	12543-12550	regions	_
67-31	12551-12555	that	_
67-32	12556-12562	showed	_
67-33	12563-12574	significant	_
67-34	12575-12580	group	_
67-35	12581-12592	differences	_
67-36	12593-12594	)	_
67-37	12595-12597	by	_
67-38	12598-12603	using	_
67-39	12604-12611	Pearson	_
67-40	12612-12623	correlation	_
67-41	12624-12626	in	_
67-42	12627-12630	IBM	_
67-43	12631-12635	SPSS	_
67-44	12636-12640	v.23	_
67-45	12641-12642	.	_

68-1	12643-12644	A	_
68-2	12645-12656	statistical	_
68-3	12657-12669	significance	_
68-4	12670-12675	level	_
68-5	12676-12679	was	_
68-6	12680-12683	set	_
68-7	12684-12686	at	_
68-8	12687-12688	P	_
68-9	12689-12690	<	_
68-10	12691-12695	0.05	_
68-11	12696-12701	after	_
68-12	12702-12712	correcting	_
68-13	12713-12716	for	_
68-14	12717-12725	multiple	_
68-15	12726-12737	comparisons	_
68-16	12738-12743	using	_
68-17	12744-12749	false	_
68-18	12750-12759	discovery	_
68-19	12760-12764	rate	_
68-20	12765-12766	(	_
68-21	12767-12770	FDR	_
68-22	12771-12772	)	_
68-23	12773-12774	.	_

